Radiation with chemotherapy and immunotherapy for throat cancer
Part of Cancer clinical trials.
This trial tests a new way of giving radiation along with standard chemotherapy and an immunotherapy drug for throat cancer. The goal is to see if this combination can better target the tumor, reduce side effects, and improve outcomes for patients with oropharyngeal cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have squamous cell carcinoma of the oropharynx (throat area including tonsils, base of tongue, soft palate, or back of throat)
- Your cancer must not have spread to distant organs (stage M0) and must be at a certain size or lymph node involvement
- You need to have a performance status of 0 or 1, meaning you are fully active or only limited in strenuous activity
- If your cancer is HPV-related (p16 positive), you must have a smoking history of more than 10 pack-years
- You must have adequate kidney, blood, and liver function, and not have certain infections like Hepatitis B or C (unless you are immune)
- You must not have had prior radiation to the head and neck area that would overlap, or be allergic to cisplatin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to guide radiation treatment for a type of throat cancer that is on one side only. The goal is to see if using a special scan (SPECT-CT) to map lymph drainage can help doctors decide how to treat the neck more precisely and reduce side effects.
This trial tests a new way of giving radiation therapy along with chemotherapy and immunotherapy for advanced oral cavity cancer. It aims to improve how well the treatment works while reducing side effects.
This Phase 2 study tests whether a more precisely targeted radiation plan to the neck can work for people with p16-positive oropharynx cancer that is considered “favorable risk.” Doctors use special imaging to map where lymph nodes are likely involved, aiming to treat the right areas while avoiding unnecessary treatment.
This trial tests if giving less radiation along with chemotherapy is safe and effective for people with HPV-positive throat cancer. It aims to reduce side effects while still controlling the cancer.
This trial compares two treatment combinations given with radiation for certain cancers of the throat. It also uses a lab test on the tumor (ERCC1) to help choose and study which treatment works better.
This study tests an approach called “adaptive radiotherapy,” where the radiation plan may be adjusted based on how your tumor and anatomy look during treatment. It is for adults with biopsy-proven oropharyngeal (throat) squamous cell carcinoma who are planning curative radiation, with or without chemotherapy.
Hear when a new Oropharyngeal Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.